Tag: Enhertu
AstraZeneca, Daiichi’s Enhertu steps into the FDA’s fast lane for new...
AstraZeneca and Daiichi Sankyo are rapidly gaining traction for their Enhertu in HER2-positive breast cancer. Next up? An early chance at expanding the blockbuster-to-be into...